Form 4: INTS Officer Buys Shares via Employee Stock Plan

Intensity Therapeutics' Principal Accounting Officer, John M. Wesolowski, acquired 8,918 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• John M. Wesolowski, Principal Accounting Officer of Intensity Therapeutics, Inc. (INTS), acquired 8,918 shares of common stock.
• The transaction occurred on December 31, 2025, through the Issuer's 2024 Employee Stock Purchase Plan (ESPP).
• Shares were purchased at a price of $0.262 per share.
• The purchase price was calculated as 85% of the closing price of the Issuer's common stock on July 1, 2025.
• Following this acquisition, Mr. Wesolowski beneficially owns a total of 85,354 shares of common stock.
• The transaction is exempt under SEC Rules 16b-3(c) and 16b-3(d).

Sentiment

Score: 7

Explanation: The sentiment is positive due to an insider (Principal Accounting Officer) acquiring shares, which typically signals confidence in the company's future performance and valuation.

Positives

• An officer's acquisition of shares through an Employee Stock Purchase Plan signals confidence in the company's future prospects.
• Participation in the ESPP demonstrates alignment of management's interests with those of shareholders.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The acquisition of shares by the Principal Accounting Officer through the ESPP reflects management's direct investment in the company's equity, indicating confidence in its long-term value.

Industry Context

Insider buying, particularly through an ESPP, is generally viewed positively by the market as it suggests that those with intimate knowledge of the company believe its stock is undervalued or has strong growth potential. This action aligns with a broader trend of management demonstrating commitment through personal investment.

Related Party Transactions

• The transaction involves an officer of Intensity Therapeutics acquiring shares through the company's 2024 Employee Stock Purchase Plan, which is a standard employee benefit program.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal, potentially increasing confidence in the company's stock.
• Employees participating in the ESPP benefit from purchasing shares at a discount, fostering a sense of ownership and alignment with company performance.

Key Dates

Recommendation

The acquisition of shares by a key officer, particularly through an Employee Stock Purchase Plan, is a strong indicator of insider confidence. This suggests that management believes the company's stock is a good investment at the current price, which can be a positive signal for potential investors. While a single transaction doesn't guarantee future performance, it aligns management's interests with shareholders and often precedes positive developments.

Keywords

Intensity Therapeutics, INTS, Insider Trading, Form 4, Stock Purchase, Employee Stock Purchase Plan, ESPP, Officer Transaction, Common Stock